News tagged with comprehensive cancer

results timeline


Dismissed leukemia drug helps CLL patients, studies show

Medicine & Health / Medications

created Dec 08, 2008 | popularity 4.9 / 5 (8) | comments 0

Researchers at Ohio State devised a new dosing schedule for the drug to increase its anti-tumor activity.


Drug combination may be effective against deadly melanoma, pilot study shows

Medicine & Health / Cancer

created Mar 06, 2009 | popularity 5 / 5 (4) | comments 0

By targeting and disabling a protein frequently found in melanoma tumors, doctors may be able to make the cancer more vulnerable to chemotherapy, according to early results of a clinical study conducted by researchers in ...


Checking more lymph nodes linked to cancer patient survival

Medicine & Health / Cancer

created Jul 22, 2008 | popularity 5 / 5 (3) | comments 0

Why do patients with gastric or pancreatic cancer live longer when they are treated at cancer centers or high-volume hospitals than patients treated at low-volume or community hospitals?


Minorities less likely to know about breast cancer treatment options

Medicine & Health / Cancer

created Jul 30, 2008 | popularity 5 / 5 (1) | comments 0

Nearly half of women treated for breast cancer did not know that their odds of being alive after five years are roughly the same whether they undergo mastectomy or breast conserving surgery. Minority women were even less ...


Older AML patients show promising response in drug study

Medicine & Health / Diseases

created Dec 08, 2008 | popularity 5 / 5 (1) | comments 0

Older patients with acute myloid leukemia (AML) who were once told that nothing could be done for them are finding new hope – and life – through a clinical trial at The Ohio State University Comprehensive Cancer Center – ...


Doctors' resources for off-label prescribing may be incomplete, unclear

Medicine & Health / Cancer

created Feb 16, 2009 | popularity not rated yet | comments 0

The resources doctors use to get important information about indications and reimbursement for use of cancer drugs off-label may be out-of-date and incomplete, according to a study led by researchers in the Duke Comprehensive ...